TECX · Tectonic Therapeutic, Inc.
$37.63
+1.58 (+4.38%)
At close · Aug 21
Market Cap
$735.64M
Shares
19.55M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$74.15M
-27.9%
FY2025
Diluted EPS
-$4.05
+40.7%
FY2025
Operating Cash Flow
-$60.08M
-1.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| $72.19M | $63.49M | $41.36M | $36.97M | $72.19M | $83.11M | $87.24M | $54.97M | $35.1M | $15.19M | |
| $22.74M | $20.55M | $16.65M | $7.68M | $33.25M | $35.73M | $32.99M | $20.84M | $11.15M | $3.2M | |
| — | $1.38M | $1.65M | $1.48M | $1.44M | $1.4M | $1.21M | $850K | $380K | $45K | |
| — | — | — | $5.06M | — | — | — | — | — | — | |
| $94.93M | $84.04M | $58.02M | $44.65M | $105.43M | $118.84M | $120.23M | $75.81M | $46.24M | $18.39M | |
| — | $3.72M | $3.62M | $3.58M | $2.97M | — | — | — | — | — | |
| -$94.93M | -$84.04M | -$58.02M | -$44.65M | -$105.43M | -$118.84M | -$120.23M | -$75.81M | -$46.24M | -$18.39M | |
| $40K | $63K | $107K | $152K | — | — | — | — | — | — | |
| $9.67M | $11.3M | $4.26M | $581K | — | — | $719K | $2.93M | $1.73M | $57K | |
| $9.47M | $11.12M | $33K | $1.83M | -$456K | -$285K | $516K | $2.84M | -$118K | -$262K | |
| — | -$72.92M | -$57.98M | — | — | — | — | — | — | — | |
| — | $1.23M | $0 | $0 | $0 | — | — | — | — | — | |
| -$85.79M | -$74.15M | -$57.98M | -$42.82M | -$105.89M | -$119.13M | -$119.71M | -$72.97M | -$46.36M | -$18.65M | |
| -$85.79M | -$74.15M | -$57.98M | -$42.82M | -$105.89M | — | — | — | — | — | |
| -$118.73M | — | — | — | — | -$119.13M | -$119.71M | -$72.97M | -$46.36M | -$18.65M | |
| USD/shares | — | -$4.05 | -$6.83 | -$33.76 | -$29.04 | -$33.36 | — | — | — | — |
| USD/shares | — | -$4.05 | -$6.83 | -$33.76 | -$29.04 | -$33.36 | — | — | — | — |
| shares | — | 18.32M | 8.49M | 1.27M | 3.64M | 3571.1667 | 3.02M | 2.29M | 1.12M | 186.32K |
| shares | — | 18.32M | 8.49M | 1.27M | 3.64M | 3571.1667 | 3.02M | 2.29M | 1.12M | 186.32K |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 5.18×
EV/EBIT
—
Peer median 23.49×
P/E (TTM)
—
Peer median 13.64×
Peer medians compare against the 309 similar-size Biotechnology companies (of 546 listed).
Key facts
CIK
1681087
CUSIP
878972108
13F (30d)
112 filings
112 filers
Visit website
Investor relations